BeiGene Ltd (NAS:BGNE)
$ 205.75 -9.25 (-4.3%) Market Cap: 23.54 Bil Enterprise Value: 22.24 Bil PE Ratio: 0 PB Ratio: 6.36 GF Score: 81/100

Beigene Ltd Investors and Analysts Panel Event Presentation Transcript

Dec 11, 2023 / 04:00AM GMT
Release Date Price: $174.54 (-0.26%)
Julia Aijun Wang Beigene Ltd;Chief Financial Officer

Presentation
Dec 11, 2023 / 04:00AM GMT

=====================
Corporate Participants
=====================
* Julia Aijun Wang
Beigene Ltd - Chief Financial Officer
* John Oyler
Beigene Ltd - Chief Executive Officer, Founder, Director
* Lai Wang
Beigene Ltd - Director, Research
* Mehrdad Mobasher
Beigene Ltd - Chief Medical Officer

=====================
Conference Call Participants
=====================
* Mazyar Shadman
Fred Hutchinson Cancer Center - Professor
* Constantine Tam
Lymphoma Service - Head
* Hang Quach
The University of Melbourne - Professor
* John Seymour AM
The Royal Melbourne Hospital - Professor
* Michael Schmidt
Guggenheim - Analyst
* Yigal Nochomovitz
Citigroup - Analyst

=====================
-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot